Skip to main content
American Journal of Respiratory and Critical Care Medicine logoLink to American Journal of Respiratory and Critical Care Medicine
letter
. 2021 Apr 15;203(8):1042–1043. doi: 10.1164/rccm.202101-0051LE

Reply to Philip et al.: Aerosol Transmission of SARS-CoV-2: Inhalation as well as Exhalation Matters for COVID-19

Matthias Echternach 1,*, Caroline Westphalen 1, Marie Christine Köberlein 1, Sophia Gantner 1, Gregor Peters 2, Tobias Benthaus 1, Bernhard Jakubaß 2, Liudmila Kuranova 1, Michael Döllinger 2, Stefan Kniesburges 2
PMCID: PMC8048754  PMID: 33529548

From the Authors:

In the comment by Philip and colleagues, the authors state that the special inhalation patterns are also important in the transmission of coronavirus disease (COVID-19). We absolutely agree that every part of the transmission pathway, specifically 1) the absolute aerosol production during singing and speaking (1), 2) the special aerosol impulse dispersion and expansion (2), 3) the accumulation and convectional spreading of aerosols in rooms (3), and 4) the special inhalation patterns during singing (4) contribute to person-to-person transmission of the COVID-19 virus.

Although our understanding of the COVID-19 pandemic has grown recently, to the best of our knowledge, the main question remains unclarified: How high a virus dose is needed to infect a person? Whereas the transmission factors (1–3) contribute to the necessary infectious dose, factor 4 represents the rate of admission by a receiving person. In agreement with Philip and colleagues, we do believe that it is very important to understand phonation-related differences in breathing patterns. With regard to this, it has been shown that ventilation patterns differ between types of phonation, showing higher V˙e for singing in contrast to breathing (4). However, many open questions remain with regard to ventilation. For example, to the best of our knowledge, it has not yet been clarified in detail if an infection is more likely if a virus cloud has been inhaled more deeply, thereby reaching deeper parts of the breathing apparatus, nor if there is any difference between transoral and transnasal breathing. With deep breath inhalation used, for example, for louder speaking, typically the fraction of transoral inhalation increases, which does not have the same immune competence as the nose. However, as far as we know, most virus dose at the beginning of the infection is found in the nasopharynx (5), a part of the breathing system that is only encountered by transnasal breathing patterns.

Nevertheless, exhalatory characteristics such as impulse dispersion appear more important for estimating safety distances because they draw the volume and regions of the highest potential viral dose within the transmission process, inoculated in a direct compact stream. Such a stream reaches significant distances, exceeding 1.3 m (2). By contrast, during inhalation, aerosol particles must enter a person’s near field, which shows much less distance from the mouth than for exhalation. The inhalatory near field can be assumed to originate from a hemispherical volume around the mouth and nose with a small radius. In a single-subject side experiment of our study, the radius of the region from which inhaled vapor for a sustained phonation came was determined at approximately 6.5 cm. Thus, the cloud has to be quite near to the mouth of the recipient to be inhaled. To illustrate, it is quite easy to blow out a candle at a distance of 10 cm by the compact exhaling stream, but it is nearly impossible to do the same by inhalation. To provide estimations of safety distances (2), we analyzed phonation-related differences in the impulse dispersion of aerosols while not disregarding that all other parts of the transmission pathway are important for understanding the COVID-19 pandemic.

Supplementary Material

Supplements
Author disclosures

Footnotes

Supported by the State of Bavaria, Germany.

Originally Published in Press as DOI: 10.1164/rccm.202101-0051LE on February 2, 2021

Author disclosures are available with the text of this letter at www.atsjournals.org.

References

  • 1.Alsved M, Matamis A, Bohlin R, Richter M, Bengtsson P-E, Fraenkel C-J, et al. Exhaled respiratory particles during singing and talking. Aerosol Sci Technol. 2020;54:1245–1248. [Google Scholar]
  • 2.Echternach M, Gantner S, Peters G, Westphalen C, Benthaus T, Jakubaß B, et al. Impulse dispersion of aerosols during singing and speaking: a potential COVID-19 transmission pathway. Am J Respir Crit Care Med. 2020;202:1584–1587. doi: 10.1164/rccm.202009-3438LE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Prather KA, Marr LC, Schooley RT, McDiarmid MA, Wilson ME, Milton DK. Airborne transmission of SARS-CoV-2. Science. 2020;370:303–304. doi: 10.1126/science.abf0521. [DOI] [PubMed] [Google Scholar]
  • 4.Philip KEJ, Lewis A, Buttery SC, McCabe C, Fancourt D, Orton C, et al. The physiological demands of Singing for Lung Health compared to treadmill walking [preprint] medRxiv. 2020 doi: 10.1136/bmjresp-2021-000959. [accessed 2021 Feb 17]. Available from: https://www.medrxiv.org/content/10.1101/2020.12.08.20245746v1. [DOI] [PMC free article] [PubMed]
  • 5.Walsh KA, Jordan K, Clyne B, Rohde D, Drummond L, Byrne P, et al. SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J Infect. 2020;81:357–371. doi: 10.1016/j.jinf.2020.06.067. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplements
Author disclosures

Articles from American Journal of Respiratory and Critical Care Medicine are provided here courtesy of American Thoracic Society

RESOURCES